Abstract:Objective This study aimed to establish a risk prediction model for diabetic retinopathy (DR) in the Chinese type 2 diabetes mellitus (T2DM) population using few inspection indicators and to propose suggestions for chronic disease management. Methods This multi-centered retrospective cross-sectional study was conducted among 2,385 patients with T2DM. The predictors of the training set were, respectively, screened by extreme gradient boosting (XGBoost), a random forest recursive feature elimination (RF-RFE) algorithm, a backpropagation neural network (BPNN), and a least absolute shrinkage selection operator (LASSO) model. Model I, a prediction model, was established through multivariable logistic regression analysis based on the predictors repeated ≥3 times in the four screening methods. Logistic regression Model II built on the predictive factors in the previously released DR risk study was introduced into our current study to evaluate the model’s effectiveness. Nine evaluation indicators were used to compare the performance of the two prediction models, including the area under the receiver operating characteristic curve (AUROC), accuracy, precision, recall, F1 score, balanced accuracy, calibration curve, Hosmer-Lemeshow test, and Net Reclassification Index (NRI). Results When including predictors, such as glycosylated hemoglobin A1c, disease course, postprandial blood glucose, age, systolic blood pressure, and albumin/urine creatinine ratio, multivariable logistic regression Model I demonstrated a better prediction ability than Model II. Model I revealed the highest AUROC (0.703), accuracy (0.796), precision (0.571), recall (0.035), F1 score (0.066), Hosmer-Lemeshow test (0.887), NRI (0.004), and balanced accuracy (0.514). Conclusion We have built an accurate DR risk prediction model with fewer indicators for patients with T2DM. It can be used to predict the individualized risk of DR in China effectively. In addition, the model can provide powerful auxiliary technical support for the clinical and health management of patients with diabetes comorbidities.

A Risk Analysis Based on a Two-Stage Delayed Diagnosis Regression Model with Application to Chronic Disease Progression

Impact of delayed diagnosis time in estimating progression rates to hepatitis C virus-related cirrhosis and death.

A Multi-state Non-Markov Framework to Estimate Progression of Chronic Disease

Risk prediction for chronic kidney disease progression using heterogeneous electronic health record data and time series analysis

A Probabilistic Disease Progression Model for Predicting Future Clinical Outcome

Progression Prediction Model of Chronic Kidney Disease Based on Decision Tree Ant Path Optimization and Logistic Regression

Risk Estimation for Age of Chronic Diseases.

Risk Projection for Time-to-Event Outcome Leveraging Summary Statistics With Source Individual-Level Data

Semiparametric predictive inference for failure data using first-hitting-time threshold regression

Heterogeneous individual risk modelling of recurrent events

Modelling and Analysing the Dynamics of Disease Progression from Cross-Sectional Studies

Dynamic and concordance-assisted learning for risk stratification with application to Alzheimer's disease

Time-varying effect in older patients with early-stage breast cancer: a model considering the competing risks based on a time scale

Multiple-Disease Risk Predictive Modeling Based on Directed Disease Networks

Time-varying effect in the competing risks based on restricted mean time lost

A risk prediction model for type 2 diabetes mellitus complicated with retinopathy based on machine learning and its application in health management

Linear mixed model vs two-stage methods: Developing prognostic models of diabetic kidney disease progression

Regression Analysis of the Generalized Accelerated Hazards Models With Interval‐Censored Data Under Case‐Cohort Studies

Directed Disease Networks to Facilitate Multiple-Disease Risk Assessment Modeling

Dynamic Prediction of Liver Cirrhosis Risk in Chronic Hepatitis B Patients Using Longitudinal Clinical Data.

Development and Internal Validation of a Model Predicting the Risk of Recurrent Stroke for Middle-Aged and Elderly Patients: A Retrospective Cohort Study